Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps

B Brian J. Lipworth (Scottish Centre for Respiratory Research, and ENT Rhinology Clinic, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom) J Joseph K. Han (Department of Otolaryngology, Head and Neck Surgery, Eastern Virginia Medical School, Norfolk) M Martin Desrosiers (Division of Otolaryngology, Head and Neck Surgery, Centre Hospitalier de l’Université de Montréal, University of Montreal, Montreal) C Claire Hopkins (Department of Otolaryngology–Head and Neck Surgery, Guy’s and St. Thomas’ Hospital, London) S Stella E. Lee (Division of Otolaryngology, Head and Neck Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston) J Joaquim Mullol (Rhinology Unit and Smell Clinic, Department of Otorhinolaryngology, Hospital Clinic Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, University of Barcelona, Barcelona) O Oliver Pfaar (Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany) T Ting Li C Claudia Chen (Biometrics, Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD) G Gun Almqvist (Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden) M Mary Kay Margolis (Patient-Centered Science, Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD) J Julie McLaren (Global Clinical Development–Medical, Amgen, Thousand Oaks, CA) S Shankar Jagadeesh (Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD) J Jamie MacKay (Early-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom) A Ayman Megally (Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD) Åsa Hellqvist (Biometrics, Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden) V Vaishali S. Mankad (Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals Research and Development (R&D), AstraZeneca, Durham, NC) L Lila Bahadori (Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD) S Sandhia S. Ponnarambil (Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom)

Article Details

Volume / Issue Vol. 392, Issue 12
Published March 27, 2025
Pages 1178-1188
ISSN 0028-4793
Publisher Massachusetts Medical Society

Journal Info

New England Journal of Medicine

Massachusetts Medical Society

ISSN: 0028-4793 Social Sciences

Authors (19)

B

Brian J. Lipworth

Scottish Centre for Respiratory Research, and ENT Rhinology Clinic, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom

J

Joseph K. Han

Department of Otolaryngology, Head and Neck Surgery, Eastern Virginia Medical School, Norfolk

M

Martin Desrosiers

Division of Otolaryngology, Head and Neck Surgery, Centre Hospitalier de l’Université de Montréal, University of Montreal, Montreal

C

Claire Hopkins

Department of Otolaryngology–Head and Neck Surgery, Guy’s and St. Thomas’ Hospital, London

S

Stella E. Lee

Division of Otolaryngology, Head and Neck Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston

J

Joaquim Mullol

Rhinology Unit and Smell Clinic, Department of Otorhinolaryngology, Hospital Clinic Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, University of Barcelona, Barcelona

O

Oliver Pfaar

Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany

T

Ting Li

C

Claudia Chen

Biometrics, Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD

G

Gun Almqvist

Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

M

Mary Kay Margolis

Patient-Centered Science, Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD

J

Julie McLaren

Global Clinical Development–Medical, Amgen, Thousand Oaks, CA

S

Shankar Jagadeesh

Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD

J

Jamie MacKay

Early-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom

A

Ayman Megally

Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD

Åsa Hellqvist

Biometrics, Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

V

Vaishali S. Mankad

Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals Research and Development (R&D), AstraZeneca, Durham, NC

L

Lila Bahadori

Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD

S

Sandhia S. Ponnarambil

Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom